SBPC/ML and Controllab conduct research with clinical laboratories

SBPC

A poll carried out during the month of July collects the consequences of the COVID-19 pandemic from the point of view of laboratory management and the information will be a source of valuable learning for the sector

The management committee of the Brazilian Society of Clinical Pathology/Laboratory Medicine (SBPC/ML), together with Controllab, intends to know the reality of laboratories during the pandemic, from the point of view of laboratory management.

In a critical period like this, which the world is going through with the COVID-19 pandemic, clinical laboratories are essential for diagnosis, isolation of infected patients, treatment and monitoring of these patients during and after their hospitalization.

The consequences of this period for laboratory management were numerous. Thus, the aim of this survey is to document this period, learn from the successes and innovative solutions created and elaborate suggestions on how the greatest difficulties experienced were overcome.

With the support of specialists, a questionnaire was developed that includes different topics related to the topic of pandemic management. Topics are listed in the poll summary.

Controllab, a partner of SBPC/ML, acts as an impartial company, assisting in prospecting the survey with the Society and compiling the final information obtained, in accordance with its adopted privacy policy.

To participate, the laboratory must work in the clinical segment and elect a representative responsible for answering the questionnaire, in order to avoid multiple responses from the same organization.

The poll is available for contributions during the month of July/21 and the results are expected to be released in the second half of this year.

Contribute to this initiative that will document a milestone in the life of Clinical Pathology and will serve for further analysis later.

To respond, access the survey link.

Sign up for our newsletter

Receive relevant publications about labs, solutions for quality
management and optimization of business management.

LOG IN

acesso ao sitema

Estamos enfrentando alguns problemas de acesso ao sistema, pedimos a compreensão de todos. Tente novamente em alguns minutos.

COOKIES NOTICE

We use cookies and other similar technologies to improve your experience, enabling a more personalized navigation, according to the characteristics and your interest.

For more information see our Privacy and Security Policy.

PRM 0009

Accreditation Cgcre/Inmetro - Certified Reference Material Producer

Controllab has been accredited as a Certified Reference Material Producer (MRC) since 2016 by Inmetro’s General Coordination for Accreditation (CGCRE), under the PMR 0009 number. The assessment of this conformity is carried out according to the requirements established in ABNT NBR standards ISO 17034 and Inmetro, thus ensuring competence for the production of MRCs, according to the Scope of Accreditation.

CAL 0214

Accreditation Cgcre/Inmetro - Calibration Laboratory

In December 2002, the Calibration Laboratory was accredited by Inmetro’s General Coordination for Accreditation (CGCRE). With this recognition, it became an integral part of the Brazilian network of accredited laboratories, under nº214. Since then, it is periodically evaluated for the maintenance and/or extension of accreditation.

PEP 0003

Accreditation Cgcre/Inmetro - Control Laboratory

In September 2011, Controllab was accredited by Inmetro’s General Coordination for Accreditation (CGCRE) as a proficiency test provider, under nº PEP0003. Initially as part of a pilot project by Inmetro, this accreditation was based on ILAC G13: 2007 and included several clinical and hemotherapy tests. In the periodic evaluations of this accreditation, new segments and tests are included and the evaluation is now conducted according to ABNT NBR ISO/IEC 17043.

This accreditation attests to Controllab’s technical competence to develop and conduct proficiency tests in accordance with international requirements and enables it to be recognized in other countries, in accordance with mutual recognition agreements signed by Brazil in Mercosur, the Americas and Europe.